Hangzhou, Zhejiang, China | Fund Name | Location |
| Adani Ports | Ahmedabad, Gujarat, India |
| Alaska Permanent Fund | Alaska, Juneau, United States |
| Avaloq | Switzerland, Zürich, Zurich |
| Batu Capital | New York, New York, United States |
| BBVA Ventures | California, San Francisco, United States |
| Bread Ventures | - |
| Cascade Seed Fund | Bend, Oregon, United States |
| eGuarantee | Japan, Tokyo |
| Fraser Mackenzie | Canada, Ontario, Toronto |
| Furui Caizhi Guquan Jijin | China, Jiangsu, Nanjing |
| Iven | Beijing, Beijing, China |
| Kendu Partners Company | - |
| Malaysia Digital Economy Corporation (MDeC) | Malaysia, Selangor, Selangor |
| Mango Fund | Hingham, Massachusetts, United States |
| MedScience Ventures | - |
| Padberg & Partners | New York, New York, United States |
| The Baobab Network | England, London, United Kingdom |
| The New York New Media Association's Angel | District of Columbia, United States, Washington |
| United States Navy | Arlington, United States, Virginia |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Qihan Biotech | $16M | 22 Sep 2023 | Shangcheng District, Zhejiang, China | ||
Bravo | $2M | 14 Mar 2018 | Shangcheng District, Zhejiang, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Qihan Biotech | $16M | 22 Sep 2023 | Shangcheng District, Zhejiang, China | ||
Bravo | $2M | 14 Mar 2018 | Shangcheng District, Zhejiang, China |
